Skip to main content
. 2014 Aug;9(3):201–207. doi: 10.15420/icr.2014.9.3.201

Table 2: Radiation Dose Management in Percutaneous Coronary Intervention.

I. Pre-Procedure
  1. Radiation Safety Program in the Cardiac Catheterisation Laboratory
    • Dosimeter use, shielding, training/education
  1. Imaging Equipment with Operator Knowledge in Use
    1. On-screen dose assessment (Ka,r, PKA)
    2. Dose saving: “fluoroscopy store” function, adjustable pulse and frame rate, virtual collimation, last image hold.
  1. Pre-procedure dose planning
    1. Assess patient and procedural issues including patient size and lesion(s) complexity. Examine patient’s back before starting re-attempt CTO PCI procedures.
  1. Informed Patient with appropriate Consent

II. Procedure
A. Limit fluoroscopy – step on pedal only when looking at screen
B. Limit cine – use “fluoroscopy store” function when high quality imaging is not required, for example to document balloon and stent inflation
C. Limit magnification, frame rate (7.5 frames per second is preferred), and steep angles
D. Use collimation and filters to fullest extent possible
E. Vary tube angle when possible to change skin area exposed
F. Position table and image receptor appropriately: the patient should be placed as far possible from the X-ray tube and the image intensifier as close as possible to the patient
G. Keep patient and operator body parts out of field of view
H. Maximise shielding and distance from x-ray source for all personnel
I. Manage and monitor dose in real time from the beginning of the case
III. Post Procedure
A. Document radiation dose in records (fluoroscopy time, Ka,r, PKA)
B. Patient and referring physician notification for high doses
  1. Ka,r >5 Gy, chart document; inform patient; arrange follow up

  2. When Ka,r >10 Gy, qualified physicist should calculate skin dose

  3. Peak Skin Dose > 15, contact risk management (sentinel event)

C. Adverse skin effects should be referred to appropriate consultant